Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Singer, H. S.
Right arrow Articles by Tada, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Singer, H. S.
Right arrow Articles by Tada, K.
NEUROLOGY 1989;39:286
© 1989 American Academy of Neurology

Nonketotic hyperglycinemia

Studies in an atypical variant

Harvey S. Singer, MD, David Valle, MD, Kiyoshi Hayasaka, MD and Keiya Tada, MD

Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MO (Dr. Singer)
Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MO (Drs. Singer and Valle)
Department of Pediatrics, Tohoku University School of Medicine, Sendai, Japan. Dr. Valle is an investigator in the Howard Hughes Medical Institute (Drs. Hayasaka and Tada).

We diagnosed a 22-year-old man with psychomotor retardation, rare seizures, hyperglycinemia, and hyperglycinuria as an atypical variant of nonketotic hyperglycinemia (NKH). Despite this clinical phenotype and a CSF/plasma ratio confirming a mild variant, measurement of hepatic glycine cleavage activity and the P-protein component indicated the more severe neonatal variant.

Address correspondence and reprint requests to Dr. Singer, Department of Neurology, Meyer 5–109, Johns Hopkins Hospital, 600 N. Wolfe Street, Baltimore, MD 21205.

Supported in part by a grant (NIH 5-M01RR-00052) to the Pediatric Clinical Research Unit at the Johns Hopkins Hospital.

Received July 1, 1988. Accepted for publication in final form August 30, 1988.




This article has been cited by other articles:


Home page
J Child NeurolHome page
M. S. van der Knaap, R. A. Wevers, S. Kure, F. J. M. Gabreels, N. M. Verhoeven, B. van Raaij-Selten, and J. Jaeken
Increased Cerebrospinal Fluid Glycine: A Biochemical Marker for a Leukoencephalopathy With Vanishing White Matter
J Child Neurol, November 1, 1999; 14(11): 728 - 731.
[Abstract] [PDF]


Home page
J Child NeurolHome page
A. H. Jackson, D. A. Applegarth, J. R. Toone, S. Kure, and H. L. Levy
Atypical Nonketotic Hyperglycinemia With Normal Cerebrospinal Fluid to Plasma Glycine Ratio
J Child Neurol, July 1, 1999; 14(7): 464 - 467.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1989 by AAN Enterprises, Inc.